Data science shared resource to advance cancer data across Howard University and Johns Hopkins
Official title: Data Science
Funded at Howard University · NIH-11419203 · Data updated 2026-11-12
A cancer research data platform project will improve how cancer data is stored, shared, and analyzed to speed discoveries and improve patient outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Howard University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 20, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $169,433 |
| NIH project number | 5U54CA295337-03 |
| Project ID | NIH-11419203 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians working with cancer data who need advanced data management, analytics, and AI tools to study cancer.
✕Less likely to help
Direct patient participation is not described; benefits are anticipated at the research data level rather than individual patient enrollment.
What this research studies
This grant funds a data science shared resource that will build and maintain robust data tools for cancer research. It aims to ensure data quality, promote FAIR principles, and support reproducible analyses across collaborating institutions. The work will incorporate AI and advanced analytics to help researchers access and analyze cancer data more efficiently, with a focus on population-based attributes and representative analyses. The resource will also foster collaborative coding and develop analytics infrastructure that can accelerate findings relevant to cancer patients.
Why it matters
Potential benefit: If successful, this resource could speed up cancer research and lead to more accurate and generalizable insights that benefit patients.
How similar studies have gone: Many cancer centers have leveraged data science resources to improve research quality and reproducibility, though the specific shared-resource model is tailored to this collaboration.
Where this research is happening
-
Howard University
Washington, United States Active
Researchers
- Principal investigator: Ameyaw, Edmund E — Howard University
- Study coordinator: Ameyaw, Edmund E
Related research
Other NIH-funded projects on the same topics.
-
Antiviral factors that limit HIV in people with SLE
Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.
-
Gut-brain connection in Parkinson’s disease
A study in Parkinson’s disease explores how the gut may influence brain health and disease progression, using animal models to understand pathways that link the gut to brain symptoms.
-
Understanding how stem cell vesicles pick their cargo to improve therapies
Researchers are studying tiny bubbles from stem cells to learn how their contents are chosen, with the aim of making better treatments for autoimmune diseases and cancer.
-
Molecular mechanisms of HIV resistance in people with Sickle Cell Disease and Trait
A scientist at Howard University is studying why people with sickle cell disease or trait might be more resistant to HIV, in order to uncover clues for better protection and treatment.
-
Community Collaborations Core for Cancer Research and Engagement
A program at Howard University to strengthen trust between communities and cancer researchers, grow partnerships, and provide hands-on STEM experiences for students in the DC–Baltimore area.
-
Planning and Evaluation Core for a cancer research partnership
A coordinating group will guide planning, monitoring, and evaluation across cancer research, education, and community programs to ensure a cohesive, sustainable effort.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.